US Stock MarketDetailed Quotes

IBRX ImmunityBio

Watchlist
  • 2.620
  • -0.050-1.87%
Close Dec 20 16:00 ET
  • 2.650
  • +0.030+1.14%
Post 19:54 ET
1.91BMarket Cap-2.88P/E (TTM)

ImmunityBio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
7,346.34%6.11M
2,453.66%1.05M
-88.89%40K
159.17%622K
90.41%139K
-30.51%82K
17.14%41K
2,471.43%360K
-74.30%240K
-81.28%73K
Operating revenue
--5.95M
--990K
-88.89%40K
159.17%622K
752.05%622K
--0
--0
2,471.43%360K
-74.30%240K
-81.28%73K
Cost of revenue
0
0
0
0
Gross profit
7,346.34%6.11M
2,453.66%1.05M
82K
41K
Operating expense
7.66%86.36M
17.84%100.38M
-14.92%95.24M
3.17%361.99M
0.42%84.64M
-11.77%80.22M
6.94%85.19M
16.62%111.94M
5.93%350.86M
5.81%84.29M
Selling and administrative expenses
12.89%35.92M
53.82%49.25M
28.18%41.89M
26.20%129.62M
26.30%33.11M
64.76%31.82M
93.17%32.02M
-19.53%32.68M
-24.06%102.71M
-6.08%26.22M
Research and development costs
4.22%50.44M
-3.84%51.13M
-32.69%53.35M
-6.36%232.37M
-11.27%51.53M
-32.41%48.4M
-15.72%53.17M
43.13%79.26M
26.63%248.15M
12.22%58.08M
Operating profit
-0.15%-80.25M
-16.66%-99.33M
14.68%-95.2M
-3.07%-361.36M
-0.34%-84.5M
11.75%-80.14M
-6.94%-85.15M
-16.26%-111.58M
-6.16%-350.62M
-6.24%-84.22M
Net non-operating interest income expense
-15.11%-39.61M
-20.68%-38.19M
-26.40%-37.33M
-111.05%-128.34M
-16.76%-32.75M
-108.41%-34.41M
-249.49%-31.64M
-310.45%-29.53M
-333.93%-60.81M
-566.83%-28.05M
Non-operating interest income
4.59%638K
40.71%833K
-43.66%160K
-68.13%863K
-220.97%-623K
141.11%610K
-8.07%592K
-78.09%284K
223.92%2.71M
81.34%515K
Non-operating interest expense
14.92%40.25M
21.05%39.02M
25.73%37.49M
103.41%129.2M
12.48%32.13M
108.91%35.02M
232.39%32.24M
251.98%29.82M
327.74%63.52M
536.12%28.56M
Other net income (expense)
80.43%34.11M
113.70%2.94M
-106.55%-1.61M
-1,506.84%-94.19M
-3,024.06%-116.2M
591.55%18.91M
-247.86%-21.43M
14,414.20%24.53M
-5.70%-5.86M
149.23%3.97M
Gain on sale of security
149.07%34.1M
127.66%2.95M
-105.68%-1.59M
-717.75%-47.33M
-957.35%-78.29M
2,166.56%13.69M
-336.66%-10.67M
7,452.16%27.94M
255.23%7.66M
226.66%9.13M
Earnings from equity interest
--0
--0
--0
37.65%-7.55M
--0
71.84%-1.26M
-1.46%-3.96M
-1,086.29%-2.34M
-1,407.72%-12.11M
-342.59%-3.55M
Special income (charges)
----
----
----
-30.10%-886K
----
----
----
----
---681K
----
-Less:Impairment of capital assets
----
----
----
30.10%886K
----
----
----
----
--681K
----
Other non- operating income (expenses)
-99.81%12K
99.75%-17K
98.14%-20K
-5,120.92%-38.43M
-3,911.16%-37.02M
107,733.33%6.47M
-3,773.51%-6.8M
-26,825.00%-1.08M
-481.35%-736K
-1,464.41%-923K
Income before tax
10.34%-85.75M
2.63%-134.58M
-15.05%-134.13M
-39.93%-583.89M
-115.58%-233.45M
13.96%-95.64M
-45.74%-138.21M
-13.19%-116.58M
-19.28%-417.29M
-18.28%-108.29M
Income tax
0
0
0
-217.65%-40K
-217.65%-40K
0
0
0
277.78%34K
3,300.00%34K
Net income
10.34%-85.75M
2.63%-134.58M
-15.05%-134.13M
-39.91%-583.85M
-115.47%-233.41M
13.96%-95.64M
-45.74%-138.21M
-13.19%-116.58M
-19.29%-417.32M
-18.32%-108.33M
Net income continuous Operations
10.34%-85.75M
2.63%-134.58M
-15.05%-134.13M
-39.91%-583.85M
-115.47%-233.41M
13.96%-95.64M
-45.74%-138.21M
-13.19%-116.58M
-19.29%-417.32M
-18.32%-108.33M
Minority interest income
61.67%-23K
94.01%-20K
91.25%-21K
12.88%-656K
80.18%-22K
73.09%-60K
-35.22%-334K
-39.53%-240K
75.38%-753K
62.24%-111K
Net income attributable to the parent company
10.31%-85.73M
2.40%-134.56M
-15.27%-134.11M
-40.00%-583.2M
-115.67%-233.39M
13.84%-95.58M
-45.77%-137.88M
-13.15%-116.34M
-20.12%-416.57M
-18.58%-108.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.31%-85.73M
2.40%-134.56M
-15.27%-134.11M
-40.00%-583.2M
-115.67%-233.39M
13.84%-95.58M
-45.77%-137.88M
-13.15%-116.34M
-20.12%-416.57M
-18.58%-108.22M
Basic earnings per share
36.84%-0.12
37.50%-0.2
25.93%-0.2
-10.58%-1.15
-40.74%-0.38
32.14%-0.19
-33.33%-0.32
-3.85%-0.27
-16.85%-1.04
-17.39%-0.27
Diluted earnings per share
36.84%-0.12
37.50%-0.2
25.93%-0.2
-10.58%-1.15
-40.74%-0.38
32.14%-0.19
-33.33%-0.32
-3.85%-0.27
-16.85%-1.04
-17.39%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 7,346.34%6.11M2,453.66%1.05M-88.89%40K159.17%622K90.41%139K-30.51%82K17.14%41K2,471.43%360K-74.30%240K-81.28%73K
Operating revenue --5.95M--990K-88.89%40K159.17%622K752.05%622K--0--02,471.43%360K-74.30%240K-81.28%73K
Cost of revenue 0000
Gross profit 7,346.34%6.11M2,453.66%1.05M82K41K
Operating expense 7.66%86.36M17.84%100.38M-14.92%95.24M3.17%361.99M0.42%84.64M-11.77%80.22M6.94%85.19M16.62%111.94M5.93%350.86M5.81%84.29M
Selling and administrative expenses 12.89%35.92M53.82%49.25M28.18%41.89M26.20%129.62M26.30%33.11M64.76%31.82M93.17%32.02M-19.53%32.68M-24.06%102.71M-6.08%26.22M
Research and development costs 4.22%50.44M-3.84%51.13M-32.69%53.35M-6.36%232.37M-11.27%51.53M-32.41%48.4M-15.72%53.17M43.13%79.26M26.63%248.15M12.22%58.08M
Operating profit -0.15%-80.25M-16.66%-99.33M14.68%-95.2M-3.07%-361.36M-0.34%-84.5M11.75%-80.14M-6.94%-85.15M-16.26%-111.58M-6.16%-350.62M-6.24%-84.22M
Net non-operating interest income expense -15.11%-39.61M-20.68%-38.19M-26.40%-37.33M-111.05%-128.34M-16.76%-32.75M-108.41%-34.41M-249.49%-31.64M-310.45%-29.53M-333.93%-60.81M-566.83%-28.05M
Non-operating interest income 4.59%638K40.71%833K-43.66%160K-68.13%863K-220.97%-623K141.11%610K-8.07%592K-78.09%284K223.92%2.71M81.34%515K
Non-operating interest expense 14.92%40.25M21.05%39.02M25.73%37.49M103.41%129.2M12.48%32.13M108.91%35.02M232.39%32.24M251.98%29.82M327.74%63.52M536.12%28.56M
Other net income (expense) 80.43%34.11M113.70%2.94M-106.55%-1.61M-1,506.84%-94.19M-3,024.06%-116.2M591.55%18.91M-247.86%-21.43M14,414.20%24.53M-5.70%-5.86M149.23%3.97M
Gain on sale of security 149.07%34.1M127.66%2.95M-105.68%-1.59M-717.75%-47.33M-957.35%-78.29M2,166.56%13.69M-336.66%-10.67M7,452.16%27.94M255.23%7.66M226.66%9.13M
Earnings from equity interest --0--0--037.65%-7.55M--071.84%-1.26M-1.46%-3.96M-1,086.29%-2.34M-1,407.72%-12.11M-342.59%-3.55M
Special income (charges) -------------30.10%-886K-------------------681K----
-Less:Impairment of capital assets ------------30.10%886K------------------681K----
Other non- operating income (expenses) -99.81%12K99.75%-17K98.14%-20K-5,120.92%-38.43M-3,911.16%-37.02M107,733.33%6.47M-3,773.51%-6.8M-26,825.00%-1.08M-481.35%-736K-1,464.41%-923K
Income before tax 10.34%-85.75M2.63%-134.58M-15.05%-134.13M-39.93%-583.89M-115.58%-233.45M13.96%-95.64M-45.74%-138.21M-13.19%-116.58M-19.28%-417.29M-18.28%-108.29M
Income tax 000-217.65%-40K-217.65%-40K000277.78%34K3,300.00%34K
Net income 10.34%-85.75M2.63%-134.58M-15.05%-134.13M-39.91%-583.85M-115.47%-233.41M13.96%-95.64M-45.74%-138.21M-13.19%-116.58M-19.29%-417.32M-18.32%-108.33M
Net income continuous Operations 10.34%-85.75M2.63%-134.58M-15.05%-134.13M-39.91%-583.85M-115.47%-233.41M13.96%-95.64M-45.74%-138.21M-13.19%-116.58M-19.29%-417.32M-18.32%-108.33M
Minority interest income 61.67%-23K94.01%-20K91.25%-21K12.88%-656K80.18%-22K73.09%-60K-35.22%-334K-39.53%-240K75.38%-753K62.24%-111K
Net income attributable to the parent company 10.31%-85.73M2.40%-134.56M-15.27%-134.11M-40.00%-583.2M-115.67%-233.39M13.84%-95.58M-45.77%-137.88M-13.15%-116.34M-20.12%-416.57M-18.58%-108.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.31%-85.73M2.40%-134.56M-15.27%-134.11M-40.00%-583.2M-115.67%-233.39M13.84%-95.58M-45.77%-137.88M-13.15%-116.34M-20.12%-416.57M-18.58%-108.22M
Basic earnings per share 36.84%-0.1237.50%-0.225.93%-0.2-10.58%-1.15-40.74%-0.3832.14%-0.19-33.33%-0.32-3.85%-0.27-16.85%-1.04-17.39%-0.27
Diluted earnings per share 36.84%-0.1237.50%-0.225.93%-0.2-10.58%-1.15-40.74%-0.3832.14%-0.19-33.33%-0.32-3.85%-0.27-16.85%-1.04-17.39%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List